Efficacy and safety evaluation of traditional Chinese medicine combined with quadruple therapy in the treatment of helicobacter pylori infection-related diseases: a retrospective study
Not Applicable
Completed
- Conditions
- helicobacter pylori infection-related diseases
- Registration Number
- ITMCTR2100004805
- Lead Sponsor
- Jiangxi University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1.Aged 14 to 70 years, no gender limit;
2.Meet the diagnostic criteria for Hp infection (by urea breath test, serum antibody, stool antigen, gastroscopy or biopsy).
Exclusion Criteria
1. Patients with cardiovascular and cerebrovascular diseases such as coronary atherosclerotic heart disease, stroke, Alzheimer's disease, Parkinson's disease, etc.;
2. Those with incomplete medical history, medication history and related examination records;
3. Anti-Hp treatment medication course of treatment <7 days;
4. Those who took other drugs or combined other related medical history during medication.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The recurrence rate of Helicobacter pylori;Helicobacter pylori eradication rate;
- Secondary Outcome Measures
Name Time Method